Zobrazeno 1 - 10
of 291
pro vyhledávání: '"J B, Trepel"'
Autor:
Liu, Shiya1 (AUTHOR), Shen, Gaigai1 (AUTHOR), Zhou, Xuanyu2 (AUTHOR), Sun, Lixin1 (AUTHOR), Yu, Long1 (AUTHOR), Cao, Yuanting1 (AUTHOR), Shu, Xiong3 (AUTHOR) shuxiong@jst-hosp.com.cn, Ran, Yuliang1 (AUTHOR) ranyuliang@cicams.ac.cn
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-17. 17p.
Autor:
Zhang, Zicheng1,2, Sun, Xujie2, Liu, Yutao3 liuyutao@cicams.ac.cn, Zhang, Yibo1, Yang, Zijian1, Dong, Jiyan2, Wang, Nan4, Ying, Jianming2, Zhou, Meng1 zhoumeng@wmu.edu.cn, Yang, Lin2 yanglin@cicams.ac.cn
Publikováno v:
Advanced Science. 8/21/2024, Vol. 11 Issue 31, p1-15. 15p.
Autor:
Hosea, Rendy1,2 (AUTHOR), Duan, Wei1,2 (AUTHOR), Meliala, Ian Timothy Sembiring1,2 (AUTHOR), Li, Wenfang1,2 (AUTHOR), Wei, Mankun1,2 (AUTHOR), Hillary, Sharon1,2 (AUTHOR), Zhao, Hezhao3 (AUTHOR), Miyagishi, Makoto4 (AUTHOR), Wu, Shourong1,2,5 (AUTHOR) shourongwu@cqu.edu.cn, Kasim, Vivi1,2,5 (AUTHOR) vivikasim@cqu.edu.cn
Publikováno v:
Advanced Science. 7/10/2024, Vol. 11 Issue 26, p1-20. 20p.
Publikováno v:
Cytopathology. 1:239-242
Described herein is a case of childhood Burkitt's lymphoma initially presenting as a pericardial effusion. A cytological diagnosis was made from a Wright's-Giemsa stained cytospin preparation. Supporting diagnostic evidence was provided by immunologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::962205c5127a59daac96a238568432f8
https://doi.org/10.1111/j.1365-2303.1990.tb00353.x
https://doi.org/10.1111/j.1365-2303.1990.tb00353.x
Autor:
Magni A; Department of Chemistry, University of Pavia, 27100, Pavia, Italy., Sciva C; Department of Chemistry, University of Pavia, 27100, Pavia, Italy.; Institute of Chemical Sciences and Technologies (SCITEC), Italian National Research Council (CNR), 20131, Milano, Italy., Castelli M; Department of Chemistry, University of Pavia, 27100, Pavia, Italy., Digwal CS; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Rodina A; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Sharma S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Ochiana S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Patel HJ; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Shah S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Chiosis G; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Moroni E; Institute of Chemical Sciences and Technologies (SCITEC), Italian National Research Council (CNR), 20131, Milano, Italy., Colombo G; Department of Chemistry, University of Pavia, 27100, Pavia, Italy.
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2024 Sep 25; Vol. 30 (54), pp. e202401957. Date of Electronic Publication: 2024 Sep 09.
Autor:
Xie T; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Huang C; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Wang Y; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Zhang H; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Guo P; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Phann TT; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Cheng Y; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Lei L; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Tao Z; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Gao Q; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Wei H; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China., Yu CY; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, China.; Affiliated Hospital of Hunan Academy of Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha, 410013, China.
Publikováno v:
Advanced healthcare materials [Adv Healthc Mater] 2024 Jul; Vol. 13 (19), pp. e2304476. Date of Electronic Publication: 2024 Apr 03.
Publikováno v:
Cancer research. 61(3)
Transcriptional repression of the transforming growth factor (TGF)-1P type II receptor (TPRII) gene appears to be a major mechanism to inactivate TGF-beta responsiveness in many human cancers. Because histone acetylation/deacetylation plays a role in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de27aef873ea4c8c9fd655dcc755696d
https://pubmed.ncbi.nlm.nih.gov/11221885
https://pubmed.ncbi.nlm.nih.gov/11221885
Publikováno v:
Leukemia. 14(7)
Inhibitors of proteases are currently emerging as a potential anti-cancer modality. Nonselective protease inhibitors are cytotoxic to leukemia and cancer cell lines and we found that this cytotoxicity is correlated with their potency as inhibitors of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfd3b0dede8735535840303a3cab03d
https://pubmed.ncbi.nlm.nih.gov/10914553
https://pubmed.ncbi.nlm.nih.gov/10914553
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 21(3)
The murine anti-bombesin monoclonal antibody, 2A11, has been demonstrated to inhibit growth of some small-cell lung cancer (SCLC) cells in nude mice xenografts and in a clinical trial. To determine if the expression of bombesin-like peptides (BLP) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69009457224f067ce054de58a4c4ff82
https://pubmed.ncbi.nlm.nih.gov/9857994
https://pubmed.ncbi.nlm.nih.gov/9857994
Autor:
S J, Lee, M J, Ha, J, Lee, P, Nguyen, Y H, Choi, F, Pirnia, W K, Kang, X F, Wang, S J, Kim, J B, Trepel
Publikováno v:
The Journal of biological chemistry. 273(17)
Progression through the cell cycle is controlled by the induction of cyclins and the activation of cognate cyclin-dependent kinases. The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor lovastatin induces growth arrest and cell dea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2bfe0a46fa35ed9ef33d3a1a13fdd37
https://pubmed.ncbi.nlm.nih.gov/9553123
https://pubmed.ncbi.nlm.nih.gov/9553123